Hosted by FDA and NBTS in collaboration with ABC2, ABTA, Friends of Cancer Research, Kidney Cancer Research Alliance, LUNGevity Foundation, Melanoma Research Alliance, Metastatic Breast Cancer Alliance, Response Assessment in Neuro-Oncology, and the Society for Neuro-Oncology.
Workshop Goals and Objectives:
To provide a forum for open discussion among FDA, clinicians, researchers, patient advocates, and industry in neuro-oncology product development on clinical trials for patients with brain metastases
- To discuss and work toward identifying endpoints for clinical trials for patients with brain metastases
- To educate researchers and product developers about relevant regulatory science and policy issues important to CNS metastasis product development
- To accelerate the development of products for the treatment of CNS metastases
- Facilitate open discussions among major stakeholders in the field of CNS metastases
FDA will provide a free-of-charge, live webcast of this workshop. Further information regarding the webcast, including the web link for the webcast, will be made available closer to the workshop date.
For complete workshop information, registration, accommodations, etc. visit https://www.fda.gov/Drugs/NewsEvents/ucm630245.htm